124 related articles for article (PubMed ID: 16448523)
1. The serum levels of proinsulin and their relationship with IGFBP-1 in obese children.
Kamoda T; Saitoh H; Inudoh M; Miyazaki K; Matsui A
Diabetes Obes Metab; 2006 Mar; 8(2):192-6. PubMed ID: 16448523
[TBL] [Abstract][Full Text] [Related]
2. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age.
Kamoda T; Nozue H; Matsui A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):290-4. PubMed ID: 17224001
[TBL] [Abstract][Full Text] [Related]
4. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
Rasmussen MH; Juul A; Hilsted J
Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
[TBL] [Abstract][Full Text] [Related]
6. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
[TBL] [Abstract][Full Text] [Related]
7. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
Ricart W; Fernández-Real JM
Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
[TBL] [Abstract][Full Text] [Related]
8. Significance of acanthosis nigricans in childhood obesity.
Guran T; Turan S; Akcay T; Bereket A
J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
[TBL] [Abstract][Full Text] [Related]
9. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
[TBL] [Abstract][Full Text] [Related]
10. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
[TBL] [Abstract][Full Text] [Related]
11. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
12. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the insulin-like growth factor axis response to a glucose load.
Flanagan DE; Holt RI; Owens PC; Cockington RJ; Moore VM; Robinson JS; Godsland IF; Phillips DI
Acta Physiol (Oxf); 2006 Jul; 187(3):371-8. PubMed ID: 16776662
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between peripheral insulin resistance and beta-cell function in obese subjects].
Li HL; Yu YR; Yu HL; Wang C; Zhang XX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):378-81. PubMed ID: 15931874
[TBL] [Abstract][Full Text] [Related]
15. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
16. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
Głowińska-Olszewska B; Urban M
Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313
[TBL] [Abstract][Full Text] [Related]
17. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Røder ME; Porte D; Schwartz RS; Kahn SE
J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
[TBL] [Abstract][Full Text] [Related]
18. [Changes in serum levels of IGF-I and its binding proteins and their relation to microcirculation in obese patients].
Krsek M; Prázný M; Sucharda P; Marek J; Justová V; Lacinová Z
Vnitr Lek; 2001 Dec; 47(12):847-51. PubMed ID: 11826548
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
